earnings growth

Masco shares jumped 13.2% after reporting 4% Q1 sales growth and 16.9% operating margins, beating expectations despite weak housing markets.

Texas Instruments stock surges 18% on 90% data center demand spike. Analysts raise price targets above $300 as AI infrastructure buildout accelerates.

Carnival reports record Q1 revenue of $6.2 billion with 50% EPS growth, trading 62% below peaks at 12.2x P/E versus market's 25.4x, though $25.3 billion debt poses risk.

NextEra Energy reports 10% Q1 earnings growth, driven by FPL's 100,000 new customers and 14% renewable segment expansion, guiding 8%+ EPS growth through 2035.

Kinder Morgan reports 38% earnings surge in Q1 2026, driven by record U.S. LNG exports and heightened international demand amid Iran tensions, with 2% dividend increase extending nine-year growth streak.

Nasdaq could reach 30,000 by 2027 on AI tailwinds, with $NVDA and $TSM positioned as semiconductor leaders to capture infrastructure spending.

AMD positioned as top Nasdaq performer in 2026 with 60%+ data center growth and MI450 GPU launch driving 60% earnings growth versus market's 18%.

$OKE rallies 15% in 2026 while offering 5% dividend yield and 9% projected earnings growth through 2028, appearing attractive despite gains.

Eli Lilly, Vertex Pharmaceuticals, and Intuitive Surgical possess durable competitive moats—patent protection and market dominance—supporting sustained earnings growth through the 2030s.

Green Thumb stock fell 10% YTD despite analyst targets doubling current prices. A licensing deal shift to $70M fixed annual fee could significantly boost earnings as revenue expands.

Congressional insiders are buying Netflix, Broadcom, and JPMorgan Chase. The three stocks show momentum gains and attractive valuations across technology and financial sectors.

Broadcom nears $400 per share boosted by expanded Meta AI partnership extending through 2029, with valuations compressing to defensible 30x forward P/E from prior 47x-49x peaks.

CVS Health trades at 11x forward earnings with 3.46% yield, posting record $402.1B revenue and 24.5% EPS growth amid successful healthcare integration.

Rosen Law Firm urges $STLA investors to join securities lawsuit alleging false statements about earnings and electrification strategy. Deadline set for June 8, 2026.

TSMC emerges as the ultimate AI infrastructure play, controlling 72% foundry market share with 40%+ earnings growth expected through 2026.

S&P 500 earnings projected to grow 13.2% in Q1 2026, marking six consecutive quarters of double-digit growth, fueled by semiconductor boom and banking rebounds.

PepsiCo and Procter & Gamble offer 3.5% and 2.9% dividend yields respectively, with 54 and 70 consecutive years of increases, providing reliable income over growth.

Market volatility has depressed healthcare valuations. Intuitive Surgical and Abbott Laboratories now trade at attractive multiples, offering long-term investment opportunities.

Intel stock surged 66% since March 30, gaining $137 billion in value, driven by Google and Terafab partnerships. However, extreme valuations demand strong Q1 earnings on April 23 to sustain momentum.

Analysts maintain bullish stance on $NVDA with 33% upside potential, projecting $8 trillion market cap by fiscal 2028 as Blackwell and data center products drive growth.